Editors’ Picks, March 2025: Cancer Cell Senescence, Ultraviolet Protection, and More
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Tag: Pancreatic cancer
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...